BOSTON SCIENTIFIC CORP
For the period ended Mar 31, 2026. Filed May 1, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 1, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 5. Other Information
(c)
On February 19, 2026, Michael F. Mahoney, our Chairman and Chief Executive Officer, terminated a trading plan that was originally entered into on August 29, 2025 and intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The plan covered the sale of up to 478,914 shares of our common stock, including 287,264 shares to be acquired upon exercise of stock options. Transactions under the plan were based upon pre-established dates and stock price thresholds.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.